Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

May 10, 2022

Study Completion Date

May 10, 2022

Conditions
Barrett EsophagusGERD
Interventions
DEVICE

Cytosponge

In a seated position, subjects will swallow the Cytosponge capsule with 150-250 mL of water. Seven minutes and 30 seconds to ten minutes after ingestion, the sponge is then withdrawn by gentle traction on the suture. After retrieval, the string is cut and the retrieved foam sphere containing the cytological specimen is immersed in fixative and stored refrigerated (1° to 12°C \[34° to 54°F\]).

DEVICE

Transnasal Endoscopy (TNE)

In an upright position, the scope will be inserted via the nares to examine the posterior pharynx, esophagus and proximal stomach with the transnasal endoscopy approach. The scope will be withdrawn from the nares following completion of the exam.

DEVICE

Esophagogastroduodenoscopy

Laying on the subjects' left side, the flexible endoscope is inserted through the mouth to allow visualization of the esophageal mucosa from the upper esophageal sphincter all the way to the esophagogastric junction (EGJ).

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

American Gastroenterological Association

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT04301986 - Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus | Biotech Hunter | Biotech Hunter